Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
MNKD
MannKind (MNKD) Reports 49% Revenue Growth
| 2024-08-07 |
PHARMACEUTICAL
